BCM
AKTS

Bayesian Capital Management’s Akoustis Technologies Inc AKTS Stock Holding History

Bayesian Capital Management’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,940
Closed -$76.8K – 1117
2023
Q1 		$76.8K Buy
24,940
+8,900
+55% +$31.1K 0.01% 698
2022
Q4 		$45.2K Buy
+16,040
New +$50.4K 0.01% 707

Other funds holding AKTS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return

Bayesian Capital Management's AKTS Position: Q2 2023 in Review

Bayesian Capital Management sold out of Akoustis Technologies Inc (AKTS) in Q2 2023, closing a stake of 24,940 shares — an estimated $76.8K sold.

Bayesian Capital Management first reported a position in AKTS in Q4 2022 and held it in 2 quarters. The position peaked at $76.8K in Q1 2023. 131 funds tracked by Wall St. Rank hold AKTS as of Q2 2023.

  • Bayesian Capital Management reported no remaining Akoustis Technologies Inc position as of Q2 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 24,940 Akoustis Technologies Inc shares in Q2 2023, an estimated $76.8K.
  • Bayesian Capital Management first reported a position in Akoustis Technologies Inc in Q4 2022 and held it in 2 quarters.
  • Bayesian Capital Management's Akoustis Technologies Inc position peaked at $76.8K in Q1 2023.
  • 131 funds tracked by Wall St. Rank held Akoustis Technologies Inc as of Q2 2023.

Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.